This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
SciClone Pharmaceuticals, Inc.
Drug Names(s): gamma-D-glutamyl-L-tryptophan
Description: SCV-07 is a synthetic dipeptide that has demonstrated immunomodulatory activity by increasing T-cell differentiation and function, biological processes that are necessary for the body to fight off infection. SciClone's proprietary drug candidate SCV-07 (gamma-D-glutamyl-L-tryptophan) is a synthetic peptide with proven immune stimulating effects, including stimulation of T-helper 1 cells (Th1) and inhibition of IL-6-dependent STAT3 signaling.
Deal Structure: SciClone acquired exclusive worldwide rights, outside of Russia, to SCV-07 from Verta.
Partners: Verta Ltd.
Additional information available to subscribers only: